Tissue-specific gene therapy directed to tumor angiogenesis

Gene Therapy

Volumn 8, Issue 11, 2001, Pages 819-827

  Varda Bloom, N ^a   Shaish, A ^a   Gonen, A ^a   Levanon, K ^a   Greenbereger, S ^a   Ferber, S ^a   Levkovitz, H ^a   Castel, D ^a   Goldberg, I ^a   Afek, A ^a   Kopolovitc, Y ^a   Harats, D ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Adenovirus; Angiogenesis; Endothelial cells; Gene therapy; PPE 1 promoter

Indexed keywords

ENDOTHELIN 1; GREEN FLUORESCENT PROTEIN; LUCIFERASE; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENDOTHELIUM CELL; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HEART; HUMAN; HUMAN CELL; KIDNEY PARENCHYMA; LUNG CARCINOMA; LUNG METASTASIS; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; TUMOR VASCULARIZATION;

ADENOVIRIDAE; ANALYSIS OF VARIANCE; ANIMALS; AORTA; CARCINOMA, LEWIS LUNG; CATTLE; CELLS, CULTURED; ENDOTHELIN-1; ENDOTHELINS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LIVER; LUMINESCENT PROTEINS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MICROSCOPY, PHASE-CONTRAST; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS (GENETICS); PROTEIN PRECURSORS; STATISTICS, NONPARAMETRIC;

EID: 0034967245     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301472     Document Type: Article

References (42)

1. Anticancer drug targets: Approaching angiogenesis
2. Endothelium-specific in vivo gene transfer
3. Improved adenoviral vectors: Cautious optimism for gene therapy
4. Gene therapy for cancer: What have we done and where are we going?
5. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung
6. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration
7. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
8. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo
9. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo
10. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia
11. Adenovirus-mediated transfer of recombinant human (1- antitrypsin cDNA to human endothelial cells
12. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors
13. Viral vector-targeted anti-angiogenic gene therapy utilizing an angiostatin complementary DNA
14. Use of von Willebrand factor promoter to transduce suicidal gene to human endothelial cells, HUVEC
15. Targeting gene expression to endothelial cells in transgenic mice using the human intercellular adhesion molecule 2 promoter
16. Endothelial-specific gene expression directed by the tie gene promoter in vivo
17. Endothelial cell-specific expression of tumor necrosis factor alpha from KDR or E-selectin promoters following retroviral delivery
18. Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter
19. Identification of endothelin-1 cell specific regulatory region in the murine endothelin-1 gene
20. Endothelins: Polyfunctional cytokines
21. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and patophysiology
22. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand
23. Vascular endothelial growth factor increases endothelin converting enzyme expression in vascular endothelial cells
24. Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression
25. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization
26. Autocrine actions of endothelin-1 as growth factor in human ovarian carcinoma cells
27. Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells
28. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
29. Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequences
30. Expression of coxsackie adenovirus receptor and alpha v-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers
31. Requirement of vascular integrin αvβ3 for angiogenesis
32. Death to a blood vessel, death to a tumor
33. Adenoviridae: The viruses and their replication
34. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: Effect of ETA and ETB receptor blockade
35. Transcriptional regulation of endothelin-1 by erythropoietin in endothelial cells
36. Antiangiogenic gene therapy
37. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
38. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
39. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
40. Use of recombinant adenovirus for metabolic engineering of mammalian cells
41. Increase in PDX-1 levels suppresses insulin gene expression in RIN 1046-38 cells
42. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src